Skip to main content
OpenTrials

Clinical trial condition

Orthomyxoviridae Infections

Explore clinical trials studying Orthomyxoviridae Infections. Study availability and eligibility vary by location and protocol.

1,810 public trials 85 recruiting studies
Refine in advanced search Browse all conditions

Orthomyxoviridae Infections trial results

Completed

Safety, Tolerability, and Immunogenicity of the Adjuvanted Trivalent Subunit Influenza Vaccine and the Non-Adjuvanted Trivalent Subunit Influenza Vaccine Compared to the Non-Adjuvanted Trivalent Split Influenza Vaccine in Children 6 to < 72 Months of Age

NCT01346592

Conditions
Infections, Influenza Disease, Influenza, Human, +5 more
Locations
  • 401 Paideia Jeronimo Salguero 2835 Piso 1 Buenos Aires, Argentina
  • 402 Hospital de Ninos Gallo 130 Buenos Aires, Argentina
  • 403 Instituto Medico Rio Cuarto Hipolito Yrigoyen 1020 Córdoba, Argentina
  • 405 Hospital Pediatrico Nino Jesus Castro Barros 650 Córdoba, Argentina
View all 34 locations
View Trial Details
Completed

Vaccine Acceptance in Pregnant Minority Women

NCT01740310

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Bordetella Infections, +10 more
Locations
  • Grady Health System Atlanta, Georgia, United States
  • Emory University Hospital Midtown Atlanta, Georgia, United States
  • Dourron OB/Gyn Associates Clinic Decatur, Georgia, United States
  • New Millenium Obstetrics & Gynecology Riverdale, Georgia, United States
View Trial Details
Completed

Comparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age

NCT01825200

Conditions
Infections, Influenza, Influenza, Human, +5 more
Locations
  • Genova Clinical Research Tucson, Arizona, United States
  • Clinical Research of South Florida Coral Gables, Florida, United States
  • Meridian Clinical Research Savannah, Georgia, United States
  • Heartland Research Associates, LLC Wichita, Kansas, United States
View all 14 locations
View Trial Details
Completed

Peds Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels

NCT00944073

Conditions
Infections, Influenza, Influenza, Human, +5 more
Locations
  • University of Maryland School of Medicine - Center for Vaccine Development - Baltimore Baltimore, Maryland, United States
  • Children's Mercy Hospital and Clinics - Infectious Diseases Kansas City, Missouri, United States
  • Saint Louis University - Center for Vaccine Development St Louis, Missouri, United States
  • Duke Translational Medicine Institute - Clinical Vaccine Unit Durham, North Carolina, United States
View Trial Details

Related conditions